SCHEMBL4596259

SCHEMBL4596259

CC(C)(C)C(CC(O)c1ccccc1F)NC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.43
GAA P10253 1/20 0.40
ALDH1A1 P00352 2/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
CNR1 P21554 1/20 0.37
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HIF1A Q16665 1/20 0.36
MME P08473 1/20 0.36
ACE P12821 1/20 0.36
CTSA P10619 1/20 0.36
CYP3A4 P08684 1/20 0.35
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
ADRB3 P13945 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4596289 0.83 ADRB2 (0.51) KMT2AHIF1AMMEACECTSA
SCHEMBL4596291 0.81 RIPK1 (0.45) LMNASMN1; SMN2MMEACE
SCHEMBL4595044 0.81 RIPK1 (0.45) LMNASMN1; SMN2MMEACE
SCHEMBL4389472 0.81 RIPK1 (0.45) LMNASMN1; SMN2MMEACE
SCHEMBL4595555 0.80 POLB (0.39) GAASMN1; SMN2CTSA
SCHEMBL15269542 0.73 ROCK2 (0.47) CNR2GAAALDH1A1CES2CES1
SCHEMBL2532623 0.72 TDP1 (0.44) GAAALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL1529699 0.72 NPC1 (0.45) MEN1KMT2AMMEACE
SCHEMBL4595990 0.71 AOC3 (0.43) CNR2ALDH1A1CNR1LMNAMEN1
SCHEMBL4584586 0.71 GAA (0.46) CNR2GAAALDH1A1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874768-A2 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2008-01-09 EP disclosed
WO-2006113837-A2 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2006-10-26 WO disclosed